ผลของการใช้ยาแอสไพรินสำหรับการป้องกันภาวะครรภ์เป็นพิษในสตรีตั้งครรภ์ความเสี่ยงปานกลาง-สูง ในโรงพยาบาลพระนครศรีอยุธยา

Authors

  • Wipa Suntiwichaya -

Keywords:

medium-high risk pregnancy, aspirin, pre-eclampsia

Abstract

Objective: To study the effect of aspirin for pre-eclampsia prevention in medium-high-risk pregnant women at Phra Nakhon Si Ayutthaya Hospital.

Methods: This was a retrospective cohort study. Data were collected from the medical records of pregnant women at high risk for pre-eclampsia attending Phra Nakhon Si Ayutthaya Hospital between 2017 and 2022. The sample size was estimated using the formula for two population proportions, the aspirin and non-aspirin groups having 141 cases each. Data were analyzed using descriptive statistics: mean, standard deviation, number, and percentage. Inferential statistics were performed for correlation alongwith chi-square or Fisher exact and independent t-test. Moreover, the risk factors were analyzed using regression models with RR and 95% CI intervals.

Results: Of 290 cases divided equally into the group receiving or not receiving aspirin for the prevention of pre-eclampsia, the group on aspirin had 9 cases of pre-eclampsia (6.20%) compared to 12 cases (20.68%) in the group not received aspirin. The pregnant women group not receiving aspirin had a significantly higher number of cases of hypertension in pregnancy (35.17% vs 20%, p=0.004) and hypertension before pregnancy (40% vs 13.1%, p<0.001) than those receiving aspirin. Likewise, the women who received aspirin had a significantly higher number of cesarean sections than those without it (77.93% vs 67.59%, p= 0.048). The incidence of pregnancy < 37 weeks, low body weight < 2,500 grams, Apgar score 1 min ≤ 7, Vaginal delivery, transfer to NICU, and postpartum hemorrhage in the women with or without aspirin were 19.31% vs 21.38%, 17.24% vs 15.17%, 8.28% vs 11.03%, 31.72% vs 20.69%, 0% vs 1.38%, and 1.38% vs 2.07% without statistical significance between the groups. A multivariant regression analysis found that no aspirin significantly increases the incidence of gestational hypertension (Adj. RR 2.02, 95%CI; 1.17-3.45, p=0.01).

Conclusion: High blood pressure is a risk factor for pre-eclampsia, and aspirin can reduce the incidence of pre-eclampsia in pregnant women.

References

คณะอนุกรรมการมาตรฐานวิชาชีพ ราชวิทยาลัยสูตินรีแพทย์แห่งประเทศไทย. (2558). แนวทางการปฏิบัติของราชวิทยาลัยเรื่องการดูแลภาวะครรภ์เป็นพิษ. ราชวิทยาลัยสูตินรีแพทย์แห่งประเทศไทย.กรุงเทพฯ : พิมพลักษณ์.

A. C. Staff. (2019). The two-stage placental model of preeclampsia: An update, J Reprod Immunol 134-135, 1-10.

นภัส โล่ห์ตระกูล. (2563). การคัดกรองภาวะครรภ์เป็นพิษ (Pre-eclampsia screening), สืบค้นเมื่อ 16 สิงหาคม 2565. จากhttps://w1.med.cmu.ac.th/obgyn/writer/%E0%B8%99%E0%B8%A0%E0%B8% B1%E0%B8%AA-%E0%B9%82%E0%B8%A5%E0%B9%88%E0%B8%AB%E0% B9%8C%E0%B8% 95%E0%B8%A3%E0%B8%B0%E0%B8%81%E0%B8%B9%E0%B8%A5/.

กลุ่มอนามัยแม่และเด็ก สำนักส่งเสริมสุขภาพ. (2563). ระบบเฝ้าระวังมารดาตาย (MDSR System). กรมอนามัย : กระทรวงสาธารณสุข.

Atallah, A., Lecarpentier, E., Goffinet, F., Doret-Dion, M., Gaucherand, P., & Tsatsaris, V. (2017). Aspirin for Prevention of Preeclampsia. Drugs, 77(17), 1819–1831. https://doi.org/10.1007/s40265-017-0823-0.

Atallah, A., Lecarpentier, E., Goffinet, F., Gaucherand, P., Doret-Dion, M., & Tsatsaris, V. (2019). Aspirine et prééclampsie [Aspirin and preeclampsia]. Presse medicale (Paris, France: 1983), 48(1 Pt 1), 34–45. https://doi.org/10.1016/j.lpm.2018.11.022

Gan J, He H, Qi H. (2016). Preventing preeclampsia and its fetal complications with low-dose aspirin in East Asians and non-East Asians: A systematic review and meta-analysis. Hypertension in pregnancy. 2016;35(3):426-35.

Bujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J. C., & Giguère, Y. (2010). Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstetrics and gynecology, 116 (2 Pt 1), 402–414. https://doi.org/10.1097/AOG.0b013e3181e9322a

Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet Lond Engl. 2010 Aug 21;376(9741):631–44.

mis57. ภาวะความดันโลหิตสูงขณะตั้งครรภ์ (Hypertension in Pregnancy) [Internet]. Department of Obstetrics and Gynecology Faculty of Medicine Chiang Mai University. 2020 [cited 2023 Mar 17]. Available from: https://w1.med.cmu.ac.th/obgyn/lecturestopics/topic-review/6655/

ACOG Publications: January 2019: Obstetrics & Gynecology [Internet]. [cited 2023 Mar 17]. Available from https://journals.lww.com/greenjournal/Citation/2019/01000/ ACOG_Publications__January_2019.41.aspx

Downloads

Published

2024-03-25

How to Cite

1.
Suntiwichaya W. ผลของการใช้ยาแอสไพรินสำหรับการป้องกันภาวะครรภ์เป็นพิษในสตรีตั้งครรภ์ความเสี่ยงปานกลาง-สูง ในโรงพยาบาลพระนครศรีอยุธยา. Nakhonphanom Hosp J [internet]. 2024 Mar. 25 [cited 2026 Jan. 9];11(1):e264014. available from: https://he01.tci-thaijo.org/index.php/nkpjournal_9/article/view/264014

Issue

Section

Original article